{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:12:07Z","timestamp":1784682727061,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,18]]},"DOI":"10.7759\/cureus.86294","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:22:11Z","timestamp":1750267331000},"source":"Crossref","is-referenced-by-count":3,"title":["Determinants of Clinical Cure and Mortality in Patients With Stenotrophomonas maltophilia Infections: A Retrospective Analysis"],"prefix":"10.7759","author":[{"given":"Silvia","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Bartilotti Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gorgulho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00f3v\u00e3o","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Pargana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney WJ","year":"2009","unstructured":"Looney WJ, Narita M, M\u00fchlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009, 9:312-23. 10.1016\/S1473-3099(09)70083-0","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2018.1531145","article-title":"Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors","volume":"51","author":"Trifonova A","year":"2019","unstructured":"Trifonova A, Strateva T. Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. Infect Dis (Lond). 2019, 51:168-78. 10.1080\/23744235.2018.1531145","journal-title":"Infect Dis (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn301","article-title":"Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review","volume":"62","author":"Falagas ME","year":"2008","unstructured":"Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother. 2008, 62:889-94. 10.1093\/jac\/dkn301","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke JS","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012, 25:2-41. 10.1128\/CMR.00019-11","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1053","article-title":"Stenotrophomonas maltophilia outbreak associated with sink drains in an intensive care unit","volume":"9","author":"Matheu MM","year":"2022","unstructured":"Matheu MM, Rice N, Singson K, et al.. Stenotrophomonas maltophilia outbreak associated with sink drains in an intensive care unit. Open Forum Infect Dis. 2022, 9:ofac492.1053. 10.1093\/ofid\/ofac492.1053","journal-title":"Open Forum Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2020.100097","article-title":"Cluster of S.\u00a0maltophilia among patients with respiratory tract infections at an intensive care unit","volume":"2","author":"Gideskog M","year":"2020","unstructured":"Gideskog M, Welander J, Melhus \u00c5. Cluster of S.\u00a0maltophilia among patients with respiratory tract infections at an intensive care unit. Infect Prev Pract. 2020, 2:100097. 10.1016\/j.infpip.2020.100097","journal-title":"Infect Prev Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/1872208316666220512121205","article-title":"Review on Stenotrophomonas maltophilia: an emerging multidrug\u2010resistant opportunistic pathogen","volume":"16","author":"Majumdar R","year":"2022","unstructured":"Majumdar R, Karthikeyan H, Senthilnathan V, Sugumar S. Review on Stenotrophomonas maltophilia: an emerging multidrug\u2010resistant opportunistic pathogen. Recent Pat Biotechnol. 2022, 16:329-54. 10.2174\/1872208316666220512121205","journal-title":"Recent Pat Biotechnol"},{"key":"ref8","unstructured":"Healthcare-associated infections acquired in intensive care units - Annual Epidemiological Report for 2021. (2025). Accessed. February 18, 2025: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/healthcare-associated-infections-acquired-intensive-care-units-annual-0."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.84","article-title":"Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature","volume":"4","author":"Falagas ME","year":"2009","unstructured":"Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 2009, 4:1103-9. 10.2217\/fmb.09.84","journal-title":"Future Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1163439","article-title":"Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"10","author":"Banar M","year":"2023","unstructured":"Banar M, Sattari-Maraji A, Bayatinejad G, et al.. Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. Front Med (Lausanne). 2023, 10:1163439. 10.3389\/fmed.2023.1163439","journal-title":"Front Med (Lausanne)"},{"key":"ref11","unstructured":"European Committee on Antimicrobial Susceptibility Testing. clinical breakpoints - breakpoints and guidance. (2025). Accessed: February 27, 2025: http:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1322853","article-title":"A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them","volume":"13","author":"Bhaumik R","year":"2023","unstructured":"Bhaumik R, Aungkur NZ, Anderson GG. A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them. Front Cell Infect Microbiol. 2023, 13:1322853. 10.3389\/fcimb.2023.1322853","journal-title":"Front Cell Infect Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.36519\/idcm.2022.187","article-title":"Stenotrophomonas maltophilia bacteremia: from diagnosis to treatment","volume":"4","author":"Aysert-Y\u0131ld\u0131z P","year":"2022","unstructured":"Aysert-Y\u0131ld\u0131z P, Y\u0131ld\u0131z Y, Habibi H, Eser S, \u00d6zgen-Top \u00d6, \u00d6zger HS, Dizbay M. Stenotrophomonas maltophilia bacteremia: from diagnosis to treatment. Infect Dis Clin Microbiol. 2022, 4:258-67. 10.36519\/idcm.2022.187","journal-title":"Infect Dis Clin Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03846-22","article-title":"Pseudomonas aeruginosa promotes persistence of Stenotrophomonas maltophilia via increased adherence to depolarized respiratory epithelium","volume":"11","author":"McDaniel MS","year":"2023","unstructured":"McDaniel MS, Lindgren NR, Billiot CE, Valladares KN, Sumpter NA, Swords WE. Pseudomonas aeruginosa promotes persistence of Stenotrophomonas maltophilia via increased adherence to depolarized respiratory epithelium. Microbiol Spectr. 2023, 11:e0384622. 10.1128\/spectrum.03846-22","journal-title":"Microbiol Spectr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02544-w","article-title":"Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients","volume":"24","author":"R\u00f8nn C","year":"2023","unstructured":"R\u00f8nn C, Kamstrup P, Ekl\u00f6f J, et al.. Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients. Respir Res. 2023, 24:232. 10.1186\/s12931-023-02544-w","journal-title":"Respir Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa778","article-title":"Alterations of the oral microbiome and cumulative carbapenem exposure are associated with Stenotrophomonas maltophilia infection in patients with acute myeloid leukemia receiving chemotherapy","volume":"72","author":"Aitken SL","year":"2021","unstructured":"Aitken SL, Sahasrabhojane PV, Kontoyiannis DP, et al.. Alterations of the oral microbiome and cumulative carbapenem exposure are associated with Stenotrophomonas maltophilia infection in patients with acute myeloid leukemia receiving chemotherapy. Clin Infect Dis. 2021, 72:1507-13. 10.1093\/cid\/ciaa778","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S325419","article-title":"Significance of Stenotrophomonas maltophilia when detected in sputum of ambulatory patients with COPD","volume":"16","author":"Soumagne T","year":"2021","unstructured":"Soumagne T, Levesque F, Milot J, Godbout K, Lacasse Y, Maltais F. Significance of Stenotrophomonas maltophilia when detected in sputum of ambulatory patients with COPD. Int J Chron Obstruct Pulmon Dis. 2021, 16:2895-900. 10.2147\/COPD.S325419","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.808391","article-title":"Risk factors for acquired Stenotrophomonas maltophilia pneumonia in intensive care unit: a systematic review and meta\u2010analysis","volume":"8","author":"Wang N","year":"2021","unstructured":"Wang N, Tang C, Wang L. Risk factors for acquired Stenotrophomonas maltophilia pneumonia in intensive care unit: a systematic review and meta\u2010analysis. Front Med (Lausanne). 2021, 8:808391. 10.3389\/fmed.2021.808391","journal-title":"Front Med (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2324365","article-title":"Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis","volume":"56","author":"Huang C","year":"2024","unstructured":"Huang C, Lin L, Kuo S. Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis. Infect Dis (Lond). 2024, 56:335-47. 10.1080\/23744235.2024.2324365","journal-title":"Infect Dis (Lond)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116664","article-title":"Mortality rates and risk factors associated with mortality in patients with Stenotrophomonas maltophilia primary bacteraemia and pneumonia","volume":"111","author":"Hasbek M","year":"2025","unstructured":"Hasbek M, Aldemir \u00d6, \u00c7ak\u0131r K\u0131ymaz Y, Baysal C, Y\u0131ld\u0131r\u0131m D, B\u00fcy\u00fcktuna SA. Mortality rates and risk factors associated with mortality in patients with Stenotrophomonas maltophilia primary bacteraemia and pneumonia. Diagn Microbiol Infect Dis. 2025, 111:116664. 10.1016\/j.diagmicrobio.2024.116664","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2012.02.008","article-title":"Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review","volume":"81","author":"Garazi M","year":"2012","unstructured":"Garazi M, Singer C, Tai J, Ginocchio CC. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect. 2012, 81:114-8. 10.1016\/j.jhin.2012.02.008","journal-title":"J Hosp Infect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.09.396","article-title":"Stenotrophomonas maltophilia: attributable mortality may be overestimated","volume":"101","author":"Kannangara D","year":"2020","unstructured":"Kannangara D, Pandya D. Stenotrophomonas maltophilia: attributable mortality may be overestimated. Int J Infect Dis. 2020, 101:146-7. 10.1016\/j.ijid.2020.09.396","journal-title":"Int J Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/14782715221088909","article-title":"Clinical associations with carriage of pulmonary Stenotrophomonas maltophilia","volume":"52","author":"Watson L","year":"2022","unstructured":"Watson L, Priestley L, Chapman SJ, Andersson MI, Jeffery K, Flight WG. Clinical associations with carriage of pulmonary Stenotrophomonas maltophilia. J R Coll Physicians Edinb. 2022, 52:14-9. 10.1177\/14782715221088909","journal-title":"J R Coll Physicians Edinb"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-024-00685-4","article-title":"Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"23","author":"Bostanghadiri N","year":"2024","unstructured":"Bostanghadiri N, Sholeh M, Navidifar T, Dadgar-Zankbar L, Elahi Z, van Belkum A, Darban-Sarokhalil D. Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2024, 23:26. 10.1186\/s12941-024-00685-4","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref26","article-title":"CLSI M100: Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2024","unstructured":"Clinical and Laboratory Standards Institute. CLSI M100: Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, Wayne, PA; 2024."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis. 2024, 403. 10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106376","article-title":"Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID","volume":"90","author":"Soueges S","year":"2025","unstructured":"Soueges S, Faure E, Parize P, et al.. Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID. J Infect. 2025, 90:106376. 10.1016\/j.jinf.2024.106376","journal-title":"J Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00172-25","article-title":"Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia","author":"Wong-So J","year":"2025","unstructured":"Wong-So J, Magr\u00e9ault S, Carbonnelle \u00c9, Jullien V, Desgrouas M, Boulain T, Barbier F. Aztreonam plus ceftazidime-avibactam for post-neurosurgical meningitis due to Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2025, e0017225. 10.1128\/aac.00172-25","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/380150-determinants-of-clinical-cure-and-mortality-in-patients-with-stenotrophomonas-maltophilia-infections-a-retrospective-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:22:12Z","timestamp":1750267332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/380150-determinants-of-clinical-cure-and-mortality-in-patients-with-stenotrophomonas-maltophilia-infections-a-retrospective-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.86294","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}